Bristol-Myers Squibb Company
BMY
$60.58+2.19%
End of day · as of Oct 15, 2026, 5:17 PM ET
Mkt cap
$95.36B
EV/Sales
2.70
P/E ratio
13.3
FY2025 Revenue
$48.19B
EPS (TTM)
$4.54
Gross Margin (FY2025)
71.08%
Profit Margin (FY2025)
14.64%
Beta
0.39
Div yield
5.36%
Sector
Healthcare
No recent filings in cache.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 13.3.
Use this BMY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BMY income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company in the Healthcare sector.
Latest cached Bristol-Myers Squibb Company (BMY) revenue for Dec 31, 2025 was $48.19B. Net income was $7.05B. Statements: https://lician.com/financials/bmy
Bristol-Myers Squibb Company (BMY) trailing P/E is 13.3 on the latest cached fundamentals snapshot.
Bristol-Myers Squibb Company (BMY) market capitalization is $95.36B on the latest cached snapshot.
Bristol-Myers Squibb Company (BMY) cached previous close $59.28; day range $60.57 – $60.67; volume 13,480,878. Session quote: https://lician.com/quote/bmy
Bristol-Myers Squibb Company (BMY) latest cached earnings event is "BMY earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings